CEL-SCI Corp (CVM) Stock Analysis
Verdict: AVOID
Serial dilution and a 12-month insolvency countdown overshadow heavy insider buying; CVM is a binary gamble on 2027 revenue projections.
Investment score: 28/100
Analysis as of
Is CEL-SCI Corp stock worth reviewing? AI model thesis
CVM is a distressed micro-cap biotech with failing liquidity and zero revenue. Despite significant insider buying, the financial metrics signal an imminent need for capital, which usually results in shareholder dilution.
7-factor investment score
- Valuation: 30/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 20/100 (weight 15%)
CEL-SCI Corp opportunities and risks
What speaks for CVM
- Aggressive Insider Buying
What speaks against CVM
- Liquidity Crisis / Urgent Dilution Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CVM | n/a | 0.0x | n/a | 0.0% | 0.0% | -169.5% |
| HOWL | n/a | 0.0x | n/a | 0.0% | 0.0% | -230.8% |
| AEON | n/a | 0.0x | n/a | 0.0% | 0.0% | -132.1% |
| SNSE | n/a | n/a | 0.7x | 2740.8% | 3802.5% | -109.2% |
| AKTX | n/a | 0.0x | n/a | 0.0% | 0.0% | -53.4% |
| QNCX | n/a | 0.0x | 0.2x | 0.0% | 0.0% | -593.5% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -132.1% |
Frequently asked questions about CEL-SCI Corp (CVM)
Is CVM stock a good investment?
The cached TradeMates AI model rates CEL-SCI Corp as AVOID with an investment score of 28/100. CVM is a distressed micro-cap biotech with failing liquidity and zero revenue. Despite significant insider buying, the financial metrics signal an imminent need for capital, which usually results in shareholder dilution. This is algorithmic model output, not personal investment advice.
Is CVM stock a buy?
The TradeMates model verdict for CVM is AVOID with an investment score of 28/100. Treat this as a model signal to review, not a personal buy recommendation.